BOCA RATON, Fla., Jan. 8, 2018 /PRNewswire/ -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing
"The speed at which we've shipped our first units since Sensus expanded the relationship reinforces our optimism about the demand for and potential of SRT-100 to reach a major segment of the Asian population, which has the highest incidence of post-surgical keloid scar formation," said Joe Sardano, CEO, Sensus Healthcare. "We are eager to continue this important work with Chindex Medical in China in 2018 and to further expand awareness of SRT across the globe."
The SRT-100 delivers precise, calibrated, low-dose radiation that effectively destroys basal cell carcinoma and squamous cell carcinoma, as well as the non-malignant tumor cells that cause keloids. Each treatment is painless and doesn't involve cutting, bleeding, stitching or anesthesia. There is also no risk of infection or scarring and no need for reconstructive plastic surgery. The SRT-100 received clearance from the China Food and Drug Administration (CFDA) for the treatment and prevention of keloids in July 2017.
About Sensus HealthcareSensus Healthcare, Inc. is a medical device company that is committed to providing non-invasive and cost-effective treatment options for non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy X-ray technology known as superficial radiation (SRT), which is a result of over a decade of dedicated research and development. Sensus has successfully incorporated SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. For more information, visit www.sensushealthcare.com.
Media Contacts: Caitlin Kasunich / Kathryne HunterKCSA Strategic Communications212-896-1241 / firstname.lastname@example.org / email@example.com
View original content:http://www.prnewswire.com/news-releases/sensus-healthcare-brings-superficial-radiation-therapy-srt-to-china-for-keloid-prevention-and-treatment-300578750.html
SOURCE Sensus Healthcare
Subscribe to our Free Newsletters!
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...
Find out about travel shots or vaccination before you travel to your destination country. Travel ...
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...View All